Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Request a data update (TAU staff only)
Home
Experts
Research units
Research output
Prizes
Activities
Search by expertise, name or affiliation
Regulating pharmaceutical companies' financial largesse
Ronen Avraham
*
, Charles Silver
*
Corresponding author for this work
Faculty of Law
Research output
:
Contribution to journal
›
Comment/debate
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Regulating pharmaceutical companies' financial largesse'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Social Sciences
pharmaceutical
100%
amendment
93%
transparency
69%
physician
61%
Conflicts of interest regulations
51%
Israeli
47%
Israel
44%
Law
42%
Insurance law
40%
fiduciary duty
39%
assortment
36%
Class actions
35%
Government regulation
32%
health insurance
27%
self-regulation
25%
Healthcare
20%
stakeholder
18%
drug
18%
Medicine & Life Sciences
Israel
59%
Pharmaceutical Preparations
44%
Government Regulation
42%
Occupational Health Physicians
42%
Conflict of Interest
34%
Physicians
34%
Self-Control
30%
Disclosure
29%
National Health Programs
28%
Names
25%
Organizations
22%
Pressure
17%
Delivery of Health Care
16%